RE:Potential...Exactly, and that's all that should be needed to treat lung cancer as well. Rutherin and X-ray activation. No surgery at all. Lung cancer being the big one, that will turn heads.
wildbird1 wrote:
I can't believe what I am reading in this press release (25 Sept 2017).
Step 1)
In GBM cancer(Brain cancer) TLT compound will be injected intravenously (IV).
Meaning... no need to go inside the skull with invasive surgery...just a needle full of TLD-1433+transferin injected intravenously.
Step 2)
Activate the X-Ray transcranially through the skull.
Meaning ... once more, no need to go inside the skull with invasive surgery.
The whole TLT-GBM-cancer treatment is done from outside the skull, and the X-Ray energy level are so low that they can't damage any surrounding tissues.
If TLT is able to improve the X-Ray treatment so it can be adapted to other form of cancer... those that wish for a $100-300 share price could have their wishes granted.
I hope the next human trial will be GBM, so easy to process and so much potential.
First let's see what the 3/3 180 days no recurrence results are.